Envestnet Asset Management
MAIA icon

Envestnet Asset Management’s MAIA Biotechnology MAIA Stock Holding History

Envestnet Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
+44,347
New +$58.9K ﹤0.01% 4786

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Envestnet Asset Management's MAIA Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 44,347 shares worth $63.9K. The stake represents ﹤0.01% of the portfolio and ranks #4786 among its holdings.

36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Envestnet Asset Management held 44,347 shares of MAIA Biotechnology worth $63.9K as of Q2 2026.
  • MAIA Biotechnology was a new Envestnet Asset Management position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4786 holding.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.